A Phase II Study of E7389 in Patients With Breast Cancer, Previously Treated With Anthracycline, Taxane and Capecitabine
Public ClinicalTrials.gov record NCT00246090. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II Open Label Single-Arm Study of E7389 in Patients With Locally Advanced or Metastatic Breast Cancer, Previously Treated With Anthracycline, Taxane, and Capecitabine Therapy, Refractory to the Last Prior Therapy for Their Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the efficacy and safety of E7389 in Patients with locally advanced or metastatic breast cancer, previously treated with anthracycline, taxane, and capecitabine as prior therapy, and who are refractory to the last prior therapy for their disease.
Study identification
- NCT ID
- NCT00246090
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 298 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2005 (Type not available)
- Primary completion
- Sep 2007 (Actual)
- Completion
- Sep 2007 (Actual)
- Last update posted
- Jul 14, 2014
2005 – 2007
United States locations
- U.S. sites
- 60
- U.S. states
- 25
- U.S. cities
- 51
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Birmingham Hematology and Oncology | Birmingham | Alabama | 35205 | — |
| Birmingham Hematology and Oncology | Birmingham | Alabama | 35213 | — |
| Mercy Cancer Center | Hot Springs | Arkansas | 71913 | — |
| Arkansas Cancer Research Center | Little Rock | Arkansas | 72205 | — |
| Wilshire Oncology Medical Group, Inc. | La Verne | California | 91750 | — |
| Rocky Mountain Cancer Center-Midtown | Denver | Colorado | 80218 | — |
| Rocky Mountain Cancer Center-Rose | Denver | Colorado | 80220 | — |
| Rocky Mountain Cancer Center | Littleton | Colorado | 80210 | — |
| Cancer Research Network | Plantation | Florida | 33324 | — |
| Hematology-Oncology Associates | Port Saint Lucie | Florida | 34952 | — |
| Dr. Elizabeth Tan-Chiu, PA | Tamarac | Florida | 33321 | — |
| Peachtree Hematology And Oncology Consultants | Atlanta | Georgia | 30309 | — |
| University of Chicago | Chicago | Illinois | 60637 | — |
| Decatur Memorial Hospital | Decatur | Illinois | 62526 | — |
| Cancer Care and Hematology Specialist of Chicagoland | Niles | Illinois | 60714 | — |
| Central Indiana Cancer Center | Indianapolis | Indiana | 46227 | — |
| Monroe Medical Center | Munster | Indiana | 46321 | — |
| Northern Indiana Cancer Research Consortium | South Bend | Indiana | 46601 | — |
| University of Kansas Medical Center | Kansas City | Kansas | 66160 | — |
| Frederick Memorial Hospital, Regional Cancer Therapy Center | Frederick | Maryland | 21701 | — |
| Park Nicollet Institute | Minneapolis | Minnesota | 55416 | — |
| Missouri Cancer Associates | Columbia | Missouri | 65201 | — |
| Montana Cancer Specialists | Missoula | Montana | 59802 | — |
| Comprehensive Cancer Centers of Nevada | Henderson | Nevada | 89052 | — |
| New York Oncology Hematology, P.C | Albany | New York | 12208 | — |
| North Shore Hematology Oncology Associates | East Setakuet | New York | 11733 | — |
| Huntington Medical Group, PC | Huntington Station | New York | 11746 | — |
| Weill Cornell Breast Cancer Center | New York | New York | 10021 | — |
| SUNY Upstate Medical University | Syracuse | New York | 13210 | — |
| Northwestern Carolina Oncology And Hematology, PA | Hudson | North Carolina | 28602 | — |
| Raleigh Hematology Oncology Associates | Raleigh | North Carolina | 27511 | — |
| 'Signal Point Hematology/Oncology, Inc. | Middletown | Ohio | 45042 | — |
| Medical University of Ohio | Toledo | Ohio | 43614 | — |
| Cancer Care Associates | Oklahoma City | Oklahoma | 73112 | — |
| Cancer Care Associates | Oklahoma City | Oklahoma | 73120 | — |
| Cancer Care Associates | Tulsa | Oklahoma | 74136 | — |
| Willamette Valley Cancer Center | Eugene | Oregon | 97401 | — |
| Northwest Cancer Specialist Rose Qtr | Portland | Oregon | 97225 | — |
| Kaiser Permanente, Central Interstate Clinic, Hematology Oncology | Portland | Oregon | 97227 | — |
| Northwest Cancer Specialist Hoyt | Portland | Oregon | 97227 | — |
| Charleston Hematology Oncology | Charleston | South Carolina | 29403 | — |
| University of Tennessee Medical Center | Knoxville | Tennessee | 37920 | — |
| Harrington Cancer Center | Amarillo | Texas | 79106 | — |
| Texas Oncology, P.A. Bedford | Bedford | Texas | 76022 | — |
| Center For Oncology Research and Treatment, PA | Dallas | Texas | 75230 | — |
| Texas Oncology PA | Dallas | Texas | 75231 | — |
| Sammons Cancer Center-Dallas | Dallas | Texas | 75246 | — |
| El Paso Cancer Treatment Center West | El Paso | Texas | 79902 | — |
| El Paso Cancer Treatment Center | El Paso | Texas | 79915 | — |
| Texas Oncology PA | Houston | Texas | 77024 | — |
| Baylor College of Medicine, Breast Cancer Clinic | Houston | Texas | 77030 | — |
| North Texas Regional Cancer Center | Plano | Texas | 75075 | — |
| Tyler Cancer Center | Tyler | Texas | 75702 | — |
| Valley Oncology PA | Weslaco | Texas | 78596 | — |
| Utah Cancer Specialists | Salt Lake City | Utah | 84106 | — |
| Fairfax Northern VA Hematology Oncology PC | Fairfax | Virginia | 22031 | — |
| Oncology and Hematology Associates | Salem | Virginia | 24153 | — |
| Cancer Care Northwest | Spokane | Washington | 99218 | — |
| Northwest Cancer Specialist | Vancouver | Washington | 98684 | — |
| Yakima Valley Memorial Hospital | Yakima | Washington | 98902 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00246090, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 14, 2014 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00246090 live on ClinicalTrials.gov.